Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization
March 22, 2022 | Medical Communications, Nucleus Global, Strategy, patient, rare diseases
Nucleus Global, the largest specialist medical communications network in the world, announces the launch of a new consultancy to add to its family of agencies. Nucleus X Consulting consists of an agile team of specialists that combine expertise in all aspects of patient engagement along with strategic consultancy in rare disease and early-phase medical commercialization.
Product launches are becoming progressively more challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic value, and patients driving treatment decisions and impacting on success through globally connected communities. Nucleus X Consulting aims to partner with clients to drive successful drug commercialization, leveraging insights to develop targeted strategies, while ensuring that patient centricity is embedded throughout the full product life cycle.
Alex Morton, Senior Patient Engagement Director, explains “We put the patient at the heart of everything we do and are committed to improving health equity for all. Put simply, we do it because it is the right thing to do. We offer a range of different patient engagement services for our clients: generating patient and caregiver insights, designing strategies to improve outcomes and patient experience, and delivering a whole host of patient education, awareness, and support tactics.”
Amanda Henkel, VP Strategy, adds “Our aim is to help our clients accelerate their business performance, utilizing insights to develop big picture concepts – and more importantly, transforming them into actionable growth strategies. We focus on rare disease and oncology, typically working with clients at an early stage of medical commercialization, where we can have the most impact to ensure a successful launch. We are passionate about challenging ourselves and our clients to help them realize their vision – our goal isn’t to just deliver, it’s to deliver exceptional quality and exceptional results every time.”
For further information about Nucleus X Consulting, please visit www.nucleusx.com
About Nucleus X Consulting and Nucleus Global
Nucleus X Consulting consists of a group of specialist practices, with deep expertise in patient engagement, rare disease, and early-phase medical commercialization. We partner with our clients to drive successful drug commercialization, leveraging insights to develop targeted strategies, ensuring patient centricity is embedded throughout the full product lifecycle from conception to market.
Nucleus Global is the largest specialist medical communications company in the world, with 14 fully serviced agencies operating out of 14 office locations and 900+ medical communications specialists worldwide. Nucleus Global’s agencies deliver world-class compliant events, publications, and digital programs, supporting the marketing, medical affairs, and publications teams of the biggest healthcare and medical brands in the world.
This content was provided by Nucleus Global